comparemela.com

Latest Breaking News On - Md washington university school of medicine - Page 2 : comparemela.com

ACC Updates HFrEF Decision Pathway, Reinforcing the Four Pillars of Therapy

The document also strengthens advice regarding which medications should be started in all patients.

United statesThomas maddoxAmerican college of cardiologyJournal of the american college cardiologyAmerican heart associationHeart failure society of americaMd washington university school of medicineAmerican collegeHeart failure societyWashington university school

MOST: Eptifibatide, Argatroban Don t Improve on IV Thrombolysis Alone

It’s possible that other classes of antithrombotics may be worth adding to improve reperfusion, but that’s conjecture right now.

Opeolu adeoyeLarry goldsteinAndrew barretoInternational stroke conferenceMd university of kentuckyNational institutes of health strokenetMd washington university school of medicineWashington university schoolTexas health science centerInternational strokeNational institutesRankin scale

Lower Mortality With M-TEER vs Surgery, but Devil Is in the Details

A deep dive into a French study shows the benefit was seen in older, sicker patients who were at high risk for surgery.

Pierre deharoTsuyoshi kanekoFrench programme de meMd washington university school of medicinePhd centre hospitalier universitaire timoneCentre hospitalier universitaire timoneEuropean heart journalWashington university schoolSicker patientsDes syst

Socioeconomics Mire Access to All AVR Options for Aortic Stenosis

TAVI and SAVR, but not CABG, rates are disproportionately low in zip codes with a high area deprivation index.

New yorkUnited statesUniversity of pennsylvaniaGuy davidTsuyoshi kanekoJournal of the american heart associationMd washington university school of medicinePhd university of pennsylvaniaAlon bergmanAmerican collegeWashington university schoolAmerican heart associationHealthcare costUtilization project

Don t Avoid Statins in Elderly, Frail Patients: Two Retrospective Studies Argue

Statin decisions shouldn’t be based on age, frailty, or chronic kidney disease, researchers say. Patients still see benefits.

Beer shevaUnited statesOdeya barayevRichard bachMd washington university school of medicineJournal of the american geriatrics societyBen gurion university of the negevHealthcare systemWashington university schoolAmerican geriatrics societyBen gurion universityBe er shevaMisunderstanding drives statin

vimarsana © 2020. All Rights Reserved.